Anzeige
Mehr »
Login
Mittwoch, 29.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Künstliche Intelligenz lässt die Nachfrage explodieren - so profitieren Anleger
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DTUW | ISIN: US6960775020 | Ticker-Symbol: PTN
Tradegate
29.05.24
19:33 Uhr
1,750 Euro
-0,018
-1,02 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
PALATIN TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
PALATIN TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,6821,72822:51
1,6701,73822:00

Aktuelle News zur PALATIN TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.05.Earnings call: Palatin Technologies reports Q3 results, plans new trials32
15.05.PALATIN TECHNOLOGIES INC - 8-K, Current Report15
15.05.PALATIN TECHNOLOGIES INC - 10-Q, Quarterly Report8
15.05.Palatin Technologies Inc. Q3 Loss Decreases351WASHINGTON (dpa-AFX) - Palatin Technologies Inc. (PTN) revealed Loss for third quarter that decreased from the same period last yearThe company's bottom line totaled -$8.44 million, or -$0.53...
► Artikel lesen
15.05.Palatin Tech GAAP EPS of -$0.53 misses by $0.0312
15.05.Palatin Technologies, Inc.: Palatin Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update106Positive Phase 3 PL9643 MELODY-1 Pivotal Study Results Co-Primary Symptom Endpoint of Pain Met Statistical Significance (P Rapid Onset of Efficacy and Multiple Symptom Endpoints, Including the Co-Primary...
► Artikel lesen
14.05.Palatin Tech Q3 2024 Earnings Preview21
02.05.Palatin spikes as FDA clears mid-stage trial for weight loss therapy45
02.05.Palatin: FDA Clears IND Application For Bremelanotide Phase 2 Study341WASHINGTON (dpa-AFX) - Palatin Technologies, Inc. (PTN) announced the FDA has completed 30-day review of the investigational new drug application for the use of bremelanotide, a melanocortin...
► Artikel lesen
02.05.Palatin Technologies, Inc.: Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of Obesity155Phase 2 clinical study expected to begin in mid-calendar year 2024 Topline data expected by calendar year-end 2024 Hosting virtual KOL event "Beyond GLPs" on May 8, 2024 Focus will be on Company's...
► Artikel lesen
12.04.Palatin Technologies And 2 Other Stocks Under $3 Insiders Are Buying70
09.04.Palatin (PTN) Up 15% on Results From Dry Eye Disease Study27
08.04.Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data38
08.04.Palatin stock jumps 16% on positive Phase 3 data for eye drug31
08.04.Palatin Says Topline Results From The Phase 3 MELODY-1 Study Of PL9643 In Dry Eye Disease Positive377WASHINGTON (dpa-AFX) - Biopharmaceutical company Palatin Technologies, Inc. (PTN) Monday said it presented positive topline results from the Phase 3 MELODY-1 study of its drug candidate PL9643...
► Artikel lesen
08.04.Palatin Technologies, Inc.: Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024145Positive Phase 3 Study Results Included in Dr. Eric Donnenfeld's Presentation Co-Primary Symptom Endpoint of Pain Met Statistical Significance (P Statistical Significance (P Rapid Onset of Efficacy...
► Artikel lesen
14.03.PALATIN TECHNOLOGIES INC - S-1, General form for registration of securities61
29.02.Palatin pummelled as dry eye therapy underwhelms in phase 394
28.02.Palatin slumps as dry-eye drug fails to meet one of the main goals in study53
28.02.Palatin CEO claims 'a positive study on its face,' despite dry eye drug's primary endpoint miss43
Seite:  Weiter >>
53 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
7,1,106